Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes
Sign Up to like & getrecommendations! Published in 2018 at "Eye"
DOI: 10.1038/s41433-018-0114-3
Abstract: PurposeThe purpose of this study was to investigate the efficacy of intravitreal aflibercept for neovascular age-related macular degeneration (nAMD) in very elderly patients aged 90 years or older at 2 years after treatment initiation.MethodsIn this… read more here.
Keywords: aged years; acuity; group; intravitreal aflibercept ... See more keywords